Perrigo Recalls Ranitidine Tablets Due to Potential N-Nitrosodimethylamine Contamination
Perrigo Company PLC is recalling specific lots of Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, due to a CGMP deviation and possible contamination with the impurity N-nitrosodimethylamine.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves potential contamination with N-nitrosodimethylamine, a known carcinogen, which meets the rubric criteria for a Severe rating.
Plain-English summary
Perrigo Company PLC is recalling Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 8 tablets. The recall involves specific product lots identified by the codes 8CE1429, 8CE1760, 9BE2907, 9DE3183, 9EE2900, and 9JE2936. The products are distributed nationwide in the United States under the NDC codes 0113-0852-51 (Good Sense) and 0363-0852-51 (Walgreens).
The recall was initiated due to a Current Good Manufacturing Practice (CGMP) deviation and the possibility of contamination with the impurity N-nitrosodimethylamine. The U.S. Food and Drug Administration has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have purchased these specific lots of Ranitidine tablets should stop using them and contact their pharmacist or the recalling firm for further instructions. This recall is limited to the specific lot numbers and NDC codes listed above.
The recalled product
- Product
- Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 8 tablets. [NDC: Brand] NDC Good Sense:0113-0852-51; NDC Walgreens 0363-0852-51
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Ranitidine
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lots: 8CE1429
- 8CE1760
- 9BE2907
- 9DE3183
- 9EE2900
- 9JE2936
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 17 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · nitrosamine contamination
See all →- SeverePerrigo Recalls Ranitidine Tablets Due to Potential N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25
- SeverePerrigo Recalls Ranitidine Tablets Due to Potential N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25
- SeverePerrigo Recalls Ranitidine Tablets Due to Potential N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25
- SeverePerrigo Recalls Ranitidine Tablets Due to Potential N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25
- SeverePerrigo Recalls Ranitidine Tablets Due to Possible N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25